All In Biotech

Drug Trial Radar · NCT02908100

A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

A Phase II, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus

Last checked: Nov 19, 2026Latest source record: May 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 260 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

260

Actual

Start

Jan 19, 2017

Primary completion

May 28, 2019

Study completion Jul 16, 2019

Sponsor

Lead sponsor
Genentech, Inc.Roche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Sep 20, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to evaluate the safety and efficacy of GDC-0853 in combination with standard of care therapy in participants with moderate to severe active systemic lupus erythematosus (SLE).

Conditions

  • Systemic Lupus Erythematosus

Interventions

  • GDC-0853Drug

    Participants received GDC-0853 at dosages of 150 or 200mg as per the dosing schedules described above.

  • PlaceboDrug

    Participants received matching placebo to GDC-0853 at dosages of 150 and 200mg as per the dosing schedules described above.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Systemic Lupus Erythematosus Responder Index (SRI)-4 Response at Week 48Time frame: Week 48

Locations

70 sites in 12 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Valerius Medical Group & Research Ctr of Greater Long Beach

    Los Alamitos, California

  • RASF-Clinical Research Center

    Boca Raton, Florida

  • Bay Area Arthritis and Osteoporosis

    Brandon, Florida

  • Omega Research Consultants

    Orlando, Florida

  • Clinical Research of West Florida

    Tampa, Florida

  • Institute of Arthritis Research

    Idaho Falls, Idaho

  • Via Christi Research, a division of Via Christi Hospitals Wichita, Inc.

    Wichita, Kansas

  • Ochsner Clinic Foundation

    Baton Rouge, Louisiana

  • The Arthritis & Diabetes Clinic, Inc.; Research

    Monroe, Louisiana

  • Albuquerque Clinical Trials

    Albuquerque, New Mexico

  • Saint Lawrence Health System

    Canton, New York

  • New York University School of Medicine

    New York, New York

  • Shanahan Rheumatology & Immunology, PLLC

    Raleigh, North Carolina

  • Ohio State University Clinical Trials Management Office

    Columbus, Ohio

  • Tekton Research Inc

    Austin, Texas

  • Accurate Clinical Research

    Houston, Texas

  • Accurate Clinical Research

    Houston, Texas

  • Arthritis Clinic Of Central Texas

    San Marcos, Texas

  • Organizacion Medica de Investigacion

    Buenos Aires, Argentina

  • APRILLUS

    Buenos Aires, Argentina

  • Hospital Italiano de La Plata

    La Plata, Argentina

  • CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica

    San Juan, Argentina

  • Centro Medico Privado de Reumatologia; Reumathology

    San Miguel, Argentina

  • CEDOES - Diagnóstico e Pesquisa

    Vitória, Espírito Santo, Brazil

  • CIP - Centro Internacional de Pesquisa X; Pesquisa Clinica

    Goiânia, Goiás, Brazil

  • Hospital das Clinicas - UFMG

    Belo Horizonte, Minas Gerais, Brazil

  • CMiP - Centro Mineiro de Pesquisa*X*

    Juiz de Fora, Minas Gerais, Brazil

  • Edumed - Educação e Saúde SA

    Curitiba, Paraná, Brazil

  • Hospital Moinhos de Vento

    Porto Alegre, Rio Grande do Sul, Brazil

  • Centro de Pesquisas em Diabetes - CPD

    Porto Alegre, Rio Grande do Sul, Brazil

  • Clinica de Neoplasias Litoral

    Itajaí, Santa Catarina, Brazil

  • Faculdade de Medicina do ABC - FMABC

    Santo André, São Paulo, Brazil

  • Hospital Estadual Mario Covas

    Santo André, São Paulo, Brazil

  • Hospital Abreu Sodré - AACD

    São Paulo, São Paulo, Brazil

  • MHAT Plovdiv

    Plovdiv, Bulgaria

  • Medical Center "Teodora", EOOD

    Rousse, Bulgaria

  • Medical Center Excelsior OOD

    Sofia, Bulgaria

  • UMHAT "Sv. Ivan Rilski", EAD

    Sofia, Bulgaria

  • MC "Synexus - Sofia", EOOD

    Sofia, Bulgaria

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.